• Sobi launches thrombocytopenia drug Doptelet in EU pharmatimes
    November 06, 2020
    Sobi (Swedish Orphan Biovitrum) has launched Doptelet (avatrombopag) in Europe, which is approved for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD).
PharmaSources Customer Service